Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
X. Flor, S. Alvarez, L. Lamarca, L. Berta, V. Feijoo, A. Toscano, C. Carrillo (Barcelona, Spain). Gold vs GesEPOC: Are they different?. Eur Respir J 2013; 42: Suppl. 57, 2382

Member's Comments

No comment yet.

Related content which might interest you: Importance of inhalation device in asthma and COPD: A consensus using Delphi Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Assessment of the COPD patients’ care: An audit of clinical practice Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 Inhaled treatment of COPD: A delphi consensus statement Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Assessing asthma risk in primary care: Can the AAA test predict future asthma attacks? Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Monitoring of airway resistance (Raw) in exacerbation of asthma Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Inhalation technique education and its impact in asthma and COPD Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 What are common COPD symptoms in a real-life setting? The German DACCORD registry Source: International Congress 2014 – COPD markers Year: 2014 Tracheostomized (TCS) patients: Is it possible to manage noninvasively tracheobronchial secretions? Source: International Congress 2015 – Latest insights into chronic care Year: 2015 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Validation of the COPD control concept: A UK pilot Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Implementation of the patient outcomes and information service (POINTS) to improve the management of chronic obstructive pulmonary disease (COPD) in Lanarkshire Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Antileukotriens in management of paediatric asthma: The hormon-reducing force Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 Shifting respiratory care from lungs to patients: The necessity for patient-focused approach Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Predictors of good inhaler technique in asthma and COPD Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Do correct steps using pMDI technique with spacer predict no exacerbations of Asthma or COPD? Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016 The utility of remote cough monitoring in COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Inhaler competence and patient satisfaction with a DPI; results of two real-life studies in asthma and COPD Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013